Tong Ren Tang Technologies (1666) Stock Overview
Produces and distributes Chinese medicine products in Mainland China and Hong Kong. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 5/6 |
1666 Community Fair Values
See what others think this stock is worth. Follow their fair value or set your own to get alerts.
Tong Ren Tang Technologies Co. Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$4.71 |
| 52 Week High | HK$5.52 |
| 52 Week Low | HK$4.40 |
| Beta | 0.92 |
| 1 Month Change | -0.84% |
| 3 Month Change | -10.80% |
| 1 Year Change | -9.42% |
| 3 Year Change | -4.07% |
| 5 Year Change | -12.45% |
| Change since IPO | 557.21% |
Recent News & Updates
Tong Ren Tang Technologies' (HKG:1666) Soft Earnings Are Actually Better Than They Appear
Sep 02Is Tong Ren Tang Technologies Co. Ltd. (HKG:1666) Trading At A 24% Discount?
Jul 22Tong Ren Tang Technologies (HKG:1666) Has Announced A Dividend Of CN¥0.1966
Jun 15Recent updates
Shareholder Returns
| 1666 | HK Pharmaceuticals | HK Market | |
|---|---|---|---|
| 7D | -4.5% | 0.01% | -3.7% |
| 1Y | -9.4% | 63.7% | 33.6% |
Return vs Industry: 1666 underperformed the Hong Kong Pharmaceuticals industry which returned 63.7% over the past year.
Return vs Market: 1666 underperformed the Hong Kong Market which returned 33.6% over the past year.
Price Volatility
| 1666 volatility | |
|---|---|
| 1666 Average Weekly Movement | 3.0% |
| Pharmaceuticals Industry Average Movement | 6.2% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in HK Market | 14.7% |
| 10% least volatile stocks in HK Market | 3.2% |
Stable Share Price: 1666 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 1666's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1669 | 3,888 | Jia Fu Chen | www.tongrentangkj.com |
Tong Ren Tang Technologies Co. Ltd., together with its subsidiaries, produces and distributes Chinese medicine products in Mainland China and Hong Kong. It operates through The Company; Tong Ren Tang Chinese Medicine; and Others segments. The company also develops, cultivates, processes, and purchases Chinese medicinal raw materials; retails and wholesales Chinese medicine products and healthcare products; and offers ointments, healthcare products, tea drinks, food, foot care products, biological products, western medicine, and cosmetics.
Tong Ren Tang Technologies Co. Ltd. Fundamentals Summary
| 1666 fundamental statistics | |
|---|---|
| Market cap | HK$6.03b |
| Earnings (TTM) | HK$472.44m |
| Revenue (TTM) | HK$7.60b |
Is 1666 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1666 income statement (TTM) | |
|---|---|
| Revenue | CN¥6.95b |
| Cost of Revenue | CN¥4.18b |
| Gross Profit | CN¥2.77b |
| Other Expenses | CN¥2.34b |
| Earnings | CN¥431.71m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.34 |
| Gross Margin | 39.82% |
| Net Profit Margin | 6.21% |
| Debt/Equity Ratio | 21.7% |
How did 1666 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/20 01:18 |
| End of Day Share Price | 2025/11/20 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Tong Ren Tang Technologies Co. Ltd. is covered by 5 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yanyin Zhu | China International Capital Corporation Limited |
| Wentao Li | Citic Securities Co., Ltd. |
| Jun Zhou Li | Everbright Securities Co. Ltd. |
